Agios Pharmaceuticals Inc

Agios’s Principal Accounting Officer Offloads Shares Amid Executive Trading Surge — Is a Signal or Routine Portfolio Move?

Agios insider selling by Principal Accounting Officer signals a cautious investor sentiment amid active executive trading and a struggling oncology pipeline.

Agios Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

05/03/2026, 22:29

3 minutes to read

Agios Executives Trade RSUs and Shares as CEO Signals Bullish Outlook Amid UAE Expansion Effort

Insider buying and RSU grants at Agios signal confidence in mitapivat’s expansion; monitor volatility and strategic shifts for future upside.

Agios Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/03/2026, 22:43

5 minutes to read

Agios Chief Commercial Officer Buys 8,475 Shares in Market‑Neutral Trade, Signaling Confidence Ahead of Big Biotech Conference.

Agios insider buy: CCO Milanova Tsveta adds 8,475 shares, showing confidence after the 52‑week low and hinting at upcoming pipeline data.

Agios Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/01/2026, 22:39

2 minutes to read